Table 4.
Treatment | ||||||
---|---|---|---|---|---|---|
|
||||||
Control oil % | 4 | 2 | 0 | Contrast P-value | ||
|
||||||
Menhaden oil % | 0 | 2 | 4 | s.e. | Lin | Quad |
Total phospholipids | ||||||
LCn-3PUFA2 | 22.8 | 37.9 | 56.2 | 3.6 | 0.0001 | 0.71 |
Total n-3 | 23.9 | 39.0 | 59.2 | 3.8 | 0.0002 | 0.60 |
Total n-6 | 116.2 | 104.1 | 79.3 | 6.4 | 0.002 | 0.39 |
Saturated | 105.1 | 100.1 | 104.7 | 2.9 | 0.93 | 0.16 |
Intramuscular triglycerides | ||||||
LCn-3PUFA2 | 0.44 | 1.5 | 3.9 | 1.0 | 0.03 | 0.56 |
Total n-3 | 2.2 | 3.6 | 6.9 | 1.4 | 0.02 | 0.52 |
Total n-6 | 48.3 | 51.6 | 46.2 | 9.3 | 0.83 | 0.6 |
Saturated | 406 | 464 | 506 | 66 | 0.16 | 0.9 |
Period effect on total fatty acid amount in intramuscular triglycerides (index of marbling) mg/100 g fresh tissue3 | ||||||
Period | 1 | 2 | 3 | s.e. | P | |
| ||||||
515 | 1211 | 1435 | 210 | 0.02 |
Lin = linear effect of Menhaden oil amounts; Quad = quadratic effect of Menhaden oil amounts; LCn-3PUFA = long-chain n-3 polyunsaturated fatty acids; LS = least square.
LS means ± s; n = 6.
LCn-3PUFA = 20:5n-3 + 22:5n-3 + 22:6n-3.
LS means and P-value of the period term of the mixed procedure model.